Biomedical Engineering Reference
In-Depth Information
SCHEME 4.34
Solution-phase synthesis of naphthyridines.
SCHEME 4.35
Structures of selected active (
104a
,
b
,and
e
,
125
,
126
,
127
) and inactive
(
104c
and
d
,
129
) naphthyridine analogs.